Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
novartis
3
×
boston blog main
boston top stories
clinical trials
europe top stories
fda
genentech
new york top stories
roche
san francisco top stories
alirocumab
alnylam pharmaceuticals
amgen
avapritinib
billy dunn
biogen
blueprint medicines
boston
cancer
cancer drugs
capmatinib
deals
drug prices
drug pricing
eli lilly
europe blog main
evolocumab
evrysdi
gastrointestinal stromal tumors
gene therapy
inclisiran
indiana blog main
indiana top stories
ionis pharmaceuticals
life science
medullary thyroid cancer
What
drug
3
×
fda
3
×
medicines
new
therapy
acquire
address
agreed
approval
approved
approves
atrophy
billion
blueprint
brings
cancer
carries
cash
certain
cholesterol
company
compound
daily
deal
designed
evrysdi
friday
genetic
green
home
intended
latest
lights
liquid
medco
medicine
muscular
novartis
oral
pass
Language
unset
3
×
Current search:
drug
×
unset
×
fda
×
novartis
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
